A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D
- PMID: 233695
- DOI: 10.1210/jcem-47-6-1303
A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D
Abstract
Typical features of hereditary vitamin D-dependent (pseudovitamin D-deficient) rickets were observed beginning at ages 20 and 5 months in a brother and sister. Both had calcium malabsorption correctable with high doses of 25-hydroxyvitamin D. During periods of hypocalcemia they both manifested secondary hyperparathyroidism with hypophosphatemia and high serum concentrations of endogenously produced 1,25-dihydroxyvitamin D. In each, normalization of serum calcium concentration and resolution of osteomalacia were obtained with continuous administration of high doses of ergocalciferol or high doses of 1,25-dihydroxycholecalciferol. Chemical features of vitamin D deficiency were corrected in the presence of high circulating concentrations of 1,25-dihydroxyvitamin D2, produced endogenously, or of 1,25-dihydroxyvitamin D3, administered by mouth. Serum concentrations of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D were normal in five first degree relatives. We conclude that in these five first degree relatives. We conclude that in these siblings, rickets and osteomalacia resulted from a hereditary decreased sensitivity to 1,25-dihydroxyvitamin D at the intestine and perhaps other vitamin D target tissues.
Similar articles
-
Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.J Clin Invest. 1986 May;77(5):1661-7. doi: 10.1172/JCI112483. J Clin Invest. 1986. PMID: 3009551 Free PMC article.
-
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.J Clin Invest. 1980 Nov;66(5):1020-32. doi: 10.1172/JCI109930. J Clin Invest. 1980. PMID: 6253520 Free PMC article.
-
Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.J Clin Invest. 1985 Jun;75(6):1858-68. doi: 10.1172/JCI111900. J Clin Invest. 1985. PMID: 3839245 Free PMC article.
-
Hereditary resistance to 1,25-dihydroxyvitamin D.Recent Prog Horm Res. 1984;40:589-620. doi: 10.1016/b978-0-12-571140-1.50019-0. Recent Prog Horm Res. 1984. PMID: 6091196 Review. No abstract available.
-
Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II).Adv Exp Med Biol. 1986;196:391-406. doi: 10.1007/978-1-4684-5101-6_26. Adv Exp Med Biol. 1986. PMID: 3012981 Review. No abstract available.
Cited by
-
Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts.J Clin Invest. 1983 Feb;71(2):192-200. doi: 10.1172/jci110759. J Clin Invest. 1983. PMID: 6296200 Free PMC article.
-
The mechanism of end-organ resistance to 1 alpha,25-dihydroxycholecalciferol in the common marmoset.Biochem J. 1985 Apr 15;227(2):555-63. doi: 10.1042/bj2270555. Biochem J. 1985. PMID: 2988503 Free PMC article.
-
Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.J Clin Invest. 1986 May;77(5):1661-7. doi: 10.1172/JCI112483. J Clin Invest. 1986. PMID: 3009551 Free PMC article.
-
Vitamin D-dependent rickets type II.Calcif Tissue Int. 1980;31(2):89-91. doi: 10.1007/BF02407169. Calcif Tissue Int. 1980. PMID: 6770981 No abstract available.
-
Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):883-5. doi: 10.1136/bmj.284.6319.883. Br Med J (Clin Res Ed). 1982. PMID: 6279228 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical